The White House called for further review from the scientific community on human genome editing in a note issued Tuesday.» Read More
An Iowa-based chicken broiler breeding farm has initially tested positive for the h5 bird flu, according to the government.
As biotech has boomed over the last few years, so has real estate in Kendall Square in Cambridge, Massachusetts.
When Dale Messenger was paralyzed following a gunshot wound he thought he wouldn't walk again. But now he is, with the help of a wearable bionic suit.
The robots are pricy, but this hospital hopes to save labor costs.
A pending Supreme Court case on Obamacare could seriously affect small business workers, self-employed people and their families.
Ariad Pharmaceuticals' CEO will retire this year in a settlement with hedge fund Sarissa Capital, capping months of agitation.
The Great Recession seems to have led to historically low birthrates for young women.
Pfizer reported a 4 percent drop in quarterly revenue, while Merck posted earnings that topped expectations.
The government now recommends that local water systems put 0.7 milligrams of fluoride in each liter of drinking water.
Biotech is getting roughed up, after leading the market's gains this year.
A theory by a doctor at Seattle Children's Hospital indicates that inner ear damage can cause SIDS, TODAY.com reports.
Nylabone Products recalled one lot of its Puppy Starter Kit dog chews since it might be contaminated with Salmonella.
The "Halftime Report" traders give their trades for the second half.
Wellness plan incentives have coaxed employees to get on a path to better health, but the Equal Employment Opportunity Commission had posed a roadblock, until now.
How much alcohol you drink depends a lot on where you live, USA Today reports.
Obamacare customers are happier with their enrollment experience this year than last.
Chipotle will begin serving only food that is free of genetically engineered ingredients, the NYT reports.
City air pollution could hurt your brain, Harvard researchers suggested Thursday.
AstraZeneca has sharpened its focus on cancer drugs as it looks beyond a hit to sales from the launch of cheap copies of its acid pill Nexium.
Cigars have higher levels of some harmful chemicals, and some smokers may be inhaling more smoke than they think.
Get the best of CNBC in your inbox